Concepedia

Publication | Open Access

Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease

DOIFull Paper Access

263

Citations

57

References

2016

Year

Isabel Lastres‐Becker, Ángel J. García‐Yagüe, Robert H. Scannevin, Marı́a José Casarejos, Sebastian Kügler, Alberto Rábano, Antonio Cuadrado
Antioxidants and Redox Signaling

Abstract

DMF is ready for clinical validation in PD. Antioxid. Redox Signal. 25, 61-77.

References

YearCitations

Page 1